Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules

Background: An early differentiation of malignant from benign solitary pulmonary nodules (SPNs) is essential for management and prognosis of lung cancer.Objectives: Here we investigated whether measurement of circulating sex hormones could be useful for an early detection of malignancy among patients with SPNs.Methods: We recruited 47 patients with malignant SPNs, 45 patients with benign SPNs, and 32 healthy persons. Testosterone, estradiol, and progesterone were measured. Carcinoembryonic antigen (CEA) as well as TNF-α, IL-1 and IL-6 were also measured.Results: We found that sex hormones were decreased significantly in patients with malignant SPNs, as compared to patients with benign SPNs and healthy controls (P<0.05). Sex hormones levels showed a trend to decline in patients with benign SPNs as compared to normal controls, but the difference was not statistically significant (P>0.05). CEA levels were only abnormally elevated in eight patients with lung adenocarcinoma. The inflammatory cytokines were remarkably higher in both patients than in normal controls. However, there was no statistical difference in these cytokines among patients.Conclusions: The reduced sex hormones levels seemed to be uniquely associated with lung cancer. Therefore, measurement of sex hormones may have clinical potential in the diagnosis of malignancy in patients with SPNs.Keywords: solitary pulmonary nodules (SPNs), sex hormones, lung cancer, biomarker

2006 Athletic Awards Banquet

This annual banquet honors student athletes who have made significant contributions to their team and sport. The banquet was held in the Corey Union Function Room on campus.https://digitalcommons.cortland.edu/awardsbanquets/1019/thumbnail.jp

2005 Athletic Awards Banquet

This annual banquet honors student athletes who have made significant contributions to their team and sport. The banquet was held in the Corey Union Function Room on campus.https://digitalcommons.cortland.edu/awardsbanquets/1018/thumbnail.jp

2004 Athletic Awards Banquet

This annual banquet honors student athletes who have made significant contributions to their team and sport. The banquet was held in the Corey Union Function Room on campus.https://digitalcommons.cortland.edu/awardsbanquets/1017/thumbnail.jp

Experimental study of optimal energy weighting in energy-resolved CT using a CZT detector

Recent advances in energy-resolved CT can potentially improve contrast-to-noise ratio (CNR), which could subsequently reduce dose in conventional and dedicated breast CT. Two methods have been proposed for optimal energy weighting: weighting the energy-bin data prior to log normalization (projection-based weighting) and weighting the energy-bin data after log normalization (image-based weighting). Previous studies suggested that optimal projection-based and image-based energy weighting provide similar CNR improvements for energy-resolved CT compared to photon-counting or conventional energy-integrating CT. This study experimentally investigated the improvement in CNR of projection-based and image-based weighted images relative to photon-counting for six different energy-bin combinations using a bench top system with a CZT detector. The results showed CNR values ranged between 0.85 and 1.01 for the projection-based weighted images and between 0.91 and 1.43 for the image-based weighted images, relative to the CNR for the photon-counting image. The range of CNR values demonstrates the effects of energy-bin selection on CNR for a particular energy weighting scheme. The non-ideal spectral response of the CZT detector caused spectral tailing, which appears to generally reduce the CNR for the projection-based weighted images. Image-based weighting increased CNR in five of the six bin combinations despite the non-ideal spectral effects

Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy.

BackgroundGlobal gene expression levels are known to be highly dependent upon gross demographic features including age, yet identification of age-related genomic indicators has yet to be comprehensively undertaken in a disease and treatment-specific context.MethodsWe used gene expression data from CD4+ lymphocytes in the Asthma BioRepository for Integrative Genomic Exploration (Asthma BRIDGE), an open-access collection of subjects participating in genetic studies of asthma with available gene expression data. Replication population participants were Puerto Rico islanders recruited as part of the ongoing Genes environments & Admixture in Latino Americans (GALA II), who provided nasal brushings for transcript sequencing. The main outcome measure was chronic asthma control as derived by questionnaires. Genomic associations were performed using regression of chronic asthma control score on gene expression with age in years as a covariate, including a multiplicative interaction term for gene expression times age.ResultsThe SMARCD1 gene (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1) interacted with age to influence chronic asthma control on inhaled corticosteroids, with a doubling of expression leading to an increase of 1.3 units of chronic asthma control per year (95% CI [0.86, 1.74], p = 6 × 10- 9), suggesting worsening asthma control with increasing age. This result replicated in GALA II (p = 3.8 × 10- 8). Cellular assays confirmed the role of SMARCD1 in glucocorticoid response in airway epithelial cells.ConclusionFocusing on age-dependent factors may help identify novel indicators of asthma medication response. Age appears to modulate the effect of SMARCD1 on asthma control with inhaled corticosteroids

Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

INTRODUCTION: Remifentanil is an opioid with a unique pharmacokinetic profile. Its organ-independent elimination and short context-sensitive half time of 3 to 4 minutes lead to a highly predictable offset of action. We tested the hypothesis that with an analgesia-based sedation regimen with remifentanil and propofol, patients after cardiac surgery reach predefined criteria for discharge from the intensive care unit (ICU) sooner, resulting in shorter duration of time spent in the ICU, compared to a conventional regimen consisting of midazolam and fentanyl. In addition, the two regimens were compared regarding their costs. METHODS: In this prospective, open-label, randomised, single-centre study, a total of 80 patients (18 to 75 years old), who had undergone cardiac surgery, were postoperatively assigned to one of two treatment regimens for sedation in the ICU for 12 to 72 hours. Patients in the remifentanil/propofol group received remifentanil (6- max. 60 μg kg(-1 )h(-1); dose exceeds recommended labelling). Propofol (0.5 to 4.0 mg kg(-1 )h(-1)) was supplemented only in the case of insufficient sedation at maximal remifentanil dose. Patients in the midazolam/fentanyl group received midazolam (0.02 to 0.2 mg kg(-1 )h(-1)) and fentanyl (1.0 to 7.0 μg kg(-1 )h(-1)). For treatment of pain after extubation, both groups received morphine and/or non-opioid analgesics. RESULTS: The time intervals (mean values ± standard deviation) from arrival at the ICU until extubation (20.7 ± 5.2 hours versus 24.2 h ± 7.0 hours) and from arrival until eligible discharge from the ICU (46.1 ± 22.0 hours versus 62.4 ± 27.2 hours) were significantly (p < 0.05) shorter in the remifentanil/propofol group. Overall costs of the ICU stay per patient were equal (approximately €1,700 on average). CONCLUSION: Compared with midazolam/fentanyl, a remifentanil-based regimen for analgesia and sedation supplemented with propofol significantly reduced the time on mechanical ventilation and allowed earlier discharge from the ICU, at equal overall costs

2003 Athletic Awards Banquet

This annual banquet honors student athletes who have made significant contributions to their team and sport. The banquet was held in the Corey Union Function Room on campus.https://digitalcommons.cortland.edu/awardsbanquets/1016/thumbnail.jp

Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?

Epidemiologic evidence from the first large-scale studies suggests that males are more se- verely affected than females by Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). They present worse outcomes, require longer hospitalization time and have a higher mortality rate when compared with women. Scientists have speculated that female hormones, especially estrogen, could explain the better outcomes and the higher resistance to the virus observed in women. This higher resistance is due to the systemic and local effect of female hormones on the different cells. In particular, estrogens stimulate the immune system by modulating the function of B cells and improving T-helper 2 cell activity. Based on this evidence, we hypothesize the potential utility of a local nasal spray with low- dose isoflavones from soya (natural estrogen) suspended in a solution with sodium could stimu- late nasal receptor by stopping or reducing the aggressiveness of COVID-19 as already suggested by a previous animal study